Microscale oxygraphy reveals OXPHOS impairment in MRC mutant cells

► Microscale oxygraphy in human fibroblasts with genetically defined mitochondrial disease. ► This technology is more sensitive, cheaper and rapid than spectrophotometry. ► It can serve as a first-line screening in patients with suspected mitochondrial disease.